# 64Cu-LLP2A for Imaging Multiple Myeloma

> **NCT03804424** · EARLY_PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** 64Cu-LLP2A
- **DEVICE:** PET/MR
- **PROCEDURE:** Blood samples for serum stability
- **PROCEDURE:** Blood samples for metabolite analysis
- **PROCEDURE:** Urine sample
- **PROCEDURE:** Tumor biopsy
- **PROCEDURE:** Electrocardiogram
- **DEVICE:** PET/CT

## Key facts

- **NCT ID:** NCT03804424
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-20
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Drug formulation changed, opening new trial
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804424, "64Cu-LLP2A for Imaging Multiple Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03804424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*